Natural Beauty Bio-Technology Ltd
HKEX:157
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Natural Beauty Bio-Technology Ltd
HKEX:157
|
HK |
Balance Sheet
Balance Sheet Decomposition
Natural Beauty Bio-Technology Ltd
Natural Beauty Bio-Technology Ltd
Balance Sheet
Natural Beauty Bio-Technology Ltd
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
217
|
170
|
236
|
339
|
356
|
589
|
546
|
559
|
576
|
558
|
432
|
507
|
583
|
503
|
429
|
289
|
181
|
146
|
162
|
193
|
169
|
167
|
117
|
112
|
|
| Cash |
217
|
170
|
236
|
339
|
356
|
589
|
546
|
559
|
576
|
558
|
432
|
507
|
583
|
503
|
429
|
289
|
181
|
146
|
162
|
193
|
169
|
167
|
117
|
112
|
|
| Short-Term Investments |
88
|
68
|
94
|
27
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
101
|
131
|
125
|
127
|
145
|
85
|
76
|
74
|
35
|
46
|
43
|
101
|
58
|
47
|
79
|
102
|
75
|
101
|
116
|
116
|
79
|
83
|
72
|
122
|
|
| Accounts Receivables |
101
|
131
|
125
|
78
|
86
|
59
|
65
|
59
|
19
|
26
|
23
|
84
|
51
|
41
|
73
|
98
|
71
|
99
|
114
|
115
|
76
|
77
|
68
|
121
|
|
| Other Receivables |
0
|
0
|
0
|
49
|
59
|
26
|
11
|
15
|
16
|
20
|
20
|
18
|
7
|
6
|
6
|
4
|
4
|
3
|
2
|
1
|
3
|
6
|
4
|
1
|
|
| Inventory |
53
|
63
|
56
|
57
|
64
|
71
|
101
|
89
|
47
|
40
|
67
|
47
|
45
|
47
|
50
|
85
|
74
|
85
|
103
|
121
|
99
|
78
|
81
|
95
|
|
| Other Current Assets |
0
|
0
|
0
|
15
|
21
|
14
|
17
|
12
|
10
|
11
|
12
|
12
|
10
|
13
|
9
|
16
|
18
|
27
|
20
|
20
|
18
|
16
|
19
|
25
|
|
| Total Current Assets |
459
|
431
|
511
|
563
|
613
|
759
|
741
|
735
|
667
|
655
|
555
|
667
|
696
|
610
|
566
|
492
|
348
|
360
|
400
|
450
|
365
|
343
|
289
|
354
|
|
| PP&E Net |
362
|
353
|
353
|
179
|
174
|
218
|
231
|
218
|
232
|
261
|
273
|
257
|
224
|
187
|
174
|
199
|
218
|
345
|
370
|
417
|
238
|
271
|
274
|
513
|
|
| PP&E Gross |
362
|
353
|
353
|
179
|
174
|
218
|
231
|
218
|
232
|
261
|
273
|
257
|
224
|
187
|
174
|
199
|
218
|
345
|
370
|
417
|
238
|
271
|
274
|
513
|
|
| Accumulated Depreciation |
54
|
78
|
103
|
114
|
131
|
142
|
119
|
117
|
96
|
104
|
129
|
167
|
195
|
173
|
184
|
219
|
220
|
240
|
259
|
274
|
271
|
274
|
265
|
279
|
|
| Intangible Assets |
5
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
15
|
14
|
6
|
0
|
0
|
0
|
0
|
|
| Goodwill |
11
|
24
|
17
|
14
|
23
|
25
|
26
|
26
|
27
|
28
|
28
|
28
|
28
|
27
|
26
|
27
|
31
|
27
|
29
|
30
|
26
|
25
|
0
|
0
|
|
| Note Receivable |
0
|
9
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
|
| Long-Term Investments |
12
|
12
|
7
|
167
|
170
|
14
|
10
|
9
|
5
|
5
|
6
|
6
|
6
|
7
|
7
|
8
|
8
|
8
|
9
|
10
|
229
|
218
|
190
|
15
|
|
| Other Long-Term Assets |
12
|
10
|
5
|
14
|
19
|
17
|
19
|
13
|
10
|
10
|
23
|
23
|
24
|
58
|
50
|
52
|
57
|
2
|
10
|
18
|
15
|
16
|
20
|
26
|
|
| Other Assets |
11
|
24
|
17
|
14
|
23
|
25
|
26
|
26
|
27
|
28
|
28
|
28
|
28
|
27
|
26
|
27
|
31
|
27
|
29
|
30
|
26
|
25
|
0
|
0
|
|
| Total Assets |
862
N/A
|
841
-2%
|
900
+7%
|
938
+4%
|
998
+6%
|
1 032
+3%
|
1 026
-1%
|
999
-3%
|
941
-6%
|
959
+2%
|
884
-8%
|
982
+11%
|
978
0%
|
889
-9%
|
822
-7%
|
778
-5%
|
679
-13%
|
757
+12%
|
832
+10%
|
930
+12%
|
872
-6%
|
872
+0%
|
773
-11%
|
926
+20%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
83
|
54
|
56
|
17
|
17
|
22
|
14
|
12
|
13
|
22
|
18
|
21
|
19
|
15
|
21
|
22
|
21
|
26
|
26
|
15
|
10
|
21
|
26
|
36
|
|
| Accrued Liabilities |
0
|
0
|
0
|
16
|
9
|
13
|
10
|
9
|
8
|
9
|
0
|
55
|
63
|
56
|
75
|
36
|
42
|
37
|
52
|
55
|
35
|
30
|
35
|
40
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
59
|
95
|
119
|
172
|
74
|
187
|
|
| Other Current Liabilities |
17
|
19
|
30
|
74
|
82
|
70
|
134
|
98
|
125
|
124
|
108
|
105
|
110
|
73
|
67
|
58
|
63
|
72
|
67
|
73
|
86
|
60
|
53
|
56
|
|
| Total Current Liabilities |
99
|
73
|
85
|
106
|
107
|
105
|
158
|
119
|
146
|
155
|
126
|
181
|
191
|
144
|
163
|
116
|
126
|
158
|
205
|
238
|
251
|
283
|
188
|
319
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
16
|
34
|
24
|
15
|
138
|
132
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
0
|
0
|
0
|
0
|
1
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
20
|
10
|
10
|
7
|
0
|
6
|
6
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
8
|
8
|
10
|
11
|
11
|
12
|
12
|
12
|
11
|
10
|
10
|
13
|
13
|
12
|
4
|
6
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
127
N/A
|
91
-29%
|
105
+16%
|
124
+18%
|
119
-4%
|
123
+3%
|
176
+44%
|
131
-26%
|
158
+21%
|
171
+8%
|
136
-20%
|
194
+43%
|
204
+5%
|
156
-23%
|
168
+7%
|
127
-24%
|
127
0%
|
190
+49%
|
221
+16%
|
273
+23%
|
275
+1%
|
298
+8%
|
325
+9%
|
452
+39%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
200
|
|
| Retained Earnings |
205
|
218
|
236
|
273
|
316
|
310
|
548
|
561
|
442
|
427
|
378
|
408
|
406
|
409
|
368
|
311
|
243
|
265
|
272
|
308
|
277
|
262
|
159
|
169
|
|
| Additional Paid In Capital |
337
|
337
|
337
|
337
|
337
|
337
|
38
|
41
|
41
|
41
|
41
|
41
|
41
|
41
|
41
|
41
|
41
|
41
|
41
|
35
|
29
|
29
|
29
|
29
|
|
| Unrealized Security Profit/Loss |
10
|
14
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
29
|
29
|
29
|
|
| Other Equity |
18
|
18
|
6
|
4
|
26
|
63
|
64
|
66
|
100
|
120
|
129
|
139
|
127
|
82
|
46
|
98
|
68
|
62
|
98
|
115
|
62
|
54
|
31
|
47
|
|
| Total Equity |
734
N/A
|
750
+2%
|
795
+6%
|
814
+2%
|
879
+8%
|
910
+4%
|
850
-7%
|
868
+2%
|
783
-10%
|
788
+1%
|
748
-5%
|
788
+5%
|
774
-2%
|
733
-5%
|
655
-11%
|
651
-1%
|
552
-15%
|
568
+3%
|
611
+8%
|
658
+8%
|
597
-9%
|
575
-4%
|
448
-22%
|
474
+6%
|
|
| Total Liabilities & Equity |
862
N/A
|
841
-2%
|
900
+7%
|
938
+4%
|
998
+6%
|
1 032
+3%
|
1 026
-1%
|
999
-3%
|
941
-6%
|
959
+2%
|
884
-8%
|
982
+11%
|
978
0%
|
889
-9%
|
822
-7%
|
778
-5%
|
679
-13%
|
757
+12%
|
832
+10%
|
930
+12%
|
872
-6%
|
872
+0%
|
773
-11%
|
926
+20%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
2 000
|
2 000
|
2 000
|
2 000
|
2 000
|
2 000
|
2 001
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
2 002
|
|